510(k) Clearance Timeline & FDA Review Costs

Understanding the 510(k) clearance timeline and its cost requires separating two distinct categories: the FDA review clock — a statutory, MDUFA-governed process with defined targets — and the FDA user fees, which are set annually and must be verified from FDA's current-year schedule. This article covers both, with emphasis on the practical factors that extend or compress real-world timelines.

The FDA 510(k) Review Clock

FDA's MDUFA performance target is to reach a final decision on 95% of 510(k) submissions within 90 calendar days of receipt. This is measured as the "Total Time to Decision" (TTTD) — the full elapsed time from the date FDA receives a substantially complete submission to the date FDA issues its clearance decision, Not Substantially Equivalent (NSE) decision, or the manufacturer withdraws.

The 90-day clock is not a promise that your device will be cleared in 90 days. It is a performance goal that covers the portion of the timeline under FDA's control. Two factors can extend the real-world timeline significantly beyond 90 days:

• Acceptance review: FDA conducts an initial acceptance review within 15 calendar days of receipt to confirm the submission is administratively complete. If the submission is placed on Hold for acceptance deficiencies, the review clock does not start until the manufacturer submits the necessary corrections and FDA accepts the submission.
• Additional Information (AI) requests: When FDA identifies substantive questions that cannot be resolved from the submitted data, it may issue an AI request. The FDA review clock is placed on hold when an AI request is issued and restarts only after FDA receives and accepts the manufacturer's response. There is no statutory limit on how long a manufacturer may take to respond, and AI hold periods of 30–120 calendar days are common in complex submissions.

What Drives Timeline Variance

The same 90-day MDUFA target applies to all Traditional 510(k) submissions, but actual clearance timelines vary considerably by device type, submission quality, and CDRH division workload. The most important factors:

Submission Completeness

Submissions that arrive complete — with a well-organized Table of Contents, all required sections, traceable performance testing linked to predicate comparison claims, and properly formatted software and cybersecurity documentation (for software-containing devices) — tend to clear faster. Submissions with missing sections, unlabeled exhibits, or performance data that does not map clearly to the substantial equivalence comparison invite AI requests that add weeks or months to the timeline.

Device Complexity and Review Division

Novel technologies, first-of-kind predicates, or devices with extensive software, AI/ML, or wireless components are reviewed by CDRH reviewers who may consult multiple subject-matter experts before reaching a decision. Review division workload also varies — divisions reviewing high volumes of submissions may have longer internal processing queues even when individual reviewers are working efficiently.

Predicate Strength

510(k) clearance depends on demonstrating substantial equivalence to a predicate device. A strong predicate — one that shares the same intended use and similar technological characteristics — makes the reviewer's job straightforward. A weak predicate (different intended use, significantly different technology, or a predicate that was itself controversial) introduces uncertainty that reviewers resolve through questions. Every AI request adds time.

eSTAR vs. Paper Submission

FDA's eSTAR system is now required for most 510(k) submissions. eSTAR submissions are structured, checklist-based, and organized in a format FDA reviewers can navigate predictably. Properly completed eSTAR submissions are less likely to receive acceptance holds for formatting deficiencies than legacy paper-based submissions.

FDA 510(k) User Fees

A 510(k) submission requires payment of an FDA user fee at the time of submission. Fee amounts are set annually under MDUFA and differ based on the applicant's company size (standard vs. small business) and submission type. Standard fee payers pay the full 510(k) user fee; small businesses meeting FDA's statutory criteria pay a reduced fee.

Because FDA adjusts user fees each federal fiscal year (which begins October 1), quoting a specific dollar amount in this guide would produce a stale figure within months of publication. For the current fee applicable to your submission, consult FDA's published fee schedule directly:

• Current 510(k) user fees: FDA's MDUFA user fee page
• Small business qualification criteria: published on the same page, with a definition tied to gross receipts or sales thresholds

User fee waivers are available in limited circumstances — for example, for devices intended solely for pediatric populations or for certain small business applicants in their first 510(k) submission. These waivers require a formal waiver request submitted concurrently with the 510(k).

Planning a Realistic Timeline

Manufacturers planning their market entry timelines should build in buffer for the factors described above. A realistic planning framework:

• Best case (clean submission, no AI): 90–120 calendar days from submission receipt to clearance decision, including acceptance review and MDUFA processing time.
• Typical case (one AI request): 150–210 calendar days from submission receipt to clearance, depending on the AI hold period.
• Complex case (novel technology, multiple AI rounds): 9–18 months from submission to clearance is not unusual for first-of-kind devices, devices with AI/ML components subject to the SaMD framework, or devices reviewed under heightened scrutiny.

The most effective way to compress the timeline is to invest in submission quality before filing. A well-prepared 510(k) that addresses likely reviewer questions proactively — with clear predicate comparison tables, complete performance testing data linked to design outputs, and a thorough software and cybersecurity documentation section — reduces the probability of an AI request that would otherwise add months to the clearance clock.

Frequently Asked Questions

How long does FDA take to clear a 510(k)?

FDA's MDUFA performance goal is to reach a final decision on 95% of 510(k) submissions within 90 calendar days of receipt. This is called the Total Time to Decision (TTTD). The clock runs from receipt to final decision — a Substantially Equivalent (SE) decision, a Not Substantially Equivalent (NSE) decision, or a withdrawal. The 90-day MDUFA target reflects FDA's statutory commitment, but actual clearance timelines vary based on submission completeness, device complexity, and whether FDA issues an Additional Information (AI) request. An AI request pauses the FDA clock for as long as the manufacturer takes to respond.

What is an Additional Information (AI) request and how does it affect the timeline?

An Additional Information (AI) request is a formal FDA request for supplemental information, test data, or clarification during a 510(k) review. When FDA issues an AI request, the FDA review clock is placed on hold — FDA's 90-day MDUFA clock stops running until the manufacturer submits a complete response. The hold time is not counted against FDA's MDUFA target. In practice, this means submissions that receive AI requests routinely take longer than 90 days total, because the clock restarts only when FDA accepts the AI response as complete. Manufacturers should plan for an additional 30–60 calendar days per AI request when forecasting clearance timelines.

How much does the FDA 510(k) user fee cost?

FDA 510(k) user fees are set annually under MDUFA and vary by submission type and applicant size. Standard 510(k) submissions pay the full user fee; small businesses (as defined by FDA's small business criteria) may qualify for a reduced fee. Current 510(k) user fee amounts are published on FDA's website at the start of each federal fiscal year (October 1). For the current year's fee schedule, consult FDA's 510(k) user fee page directly — fee amounts change annually and the most current figure is always FDA's published schedule, not any third-party source.

What is the difference between a Traditional, Abbreviated, and Special 510(k)?

A Traditional 510(k) is the standard submission format: full device description, substantial equivalence comparison to a predicate, and all required performance testing data. An Abbreviated 510(k) may be used when FDA has issued a guidance document or a recognized consensus standard for the device type — the manufacturer can rely on that guidance or standard to demonstrate substantial equivalence with a streamlined submission. A Special 510(k) is used when a legally marketed device is being modified by its own manufacturer — the modification must not raise new questions of safety and effectiveness, and a design control summary replaces the traditional substantial equivalence analysis.